BREAKING: AstraZeneca likely provided an “incomplete view of efficacy data” on COVID-19 vaccine from a large scale U.S. trial – National Institute of Allergy and Infectious Diseases (NIAID)
TRIAL
March 23, 2021
#BREAKING: AstraZeneca likely provided an “incomplete view of efficacy data” on COVID-19 vaccine from a large scale U.S. trial – National Institute of Allergy and Infectious Diseases (NIAID) pic.twitter.com/uKEkBDr1By
— Breaking911 (@Breaking911) March 23, 2021
PRAYER & PROPHECY